Robert Woods
Förmögenhet: 2 M $ per 2026-05-31
Förmögenhet: 2 M $ per 2026-05-31
Robert Keith Woods is currently Independent Director at TScan Therapeutics, Inc. since 2023, Independent Director at Neurogene, Inc. since 2023, and Chief Operating Officer at Scholar Rock Holding Corp.
starting in 2025.
Former roles include Chief Operating Officer & Director at Rocket Pharmaceuticals, Inc. from 2023 to 2025, Vice President & Managing Director at Alexion Pharma UK Ltd., Independent Director at X4 Pharmaceuticals, Inc. from 2023 to 2025, Senior VP-North American Business Operations at Alexion Pharmaceuticals, Inc., and Chief Operating Officer-US at argenx SE from 2018 to 2023.
Education includes undergraduate studies at Florida State University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-16 | 48 034 ( 0,04 % ) | 2 M $ | 2026-05-31 | |
X4 PHARMACEUTICALS, INC. 0,01 % | 2025-06-09 | 6 000 ( 0,01 % ) | 25 860 $ | 2026-05-31 |
-.--% | 2026-04-07 | 0 ( -.--% ) | - $ | 2026-05-31 |
| 2026-05-20 | 0 ( -.--% ) | - $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-12-06 |
| SCHOLAR ROCK HOLDING CORPORATION | Verksamhetschef | 2025-04-27 |
| Företag | Position | Slut |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2025-08-22 |
| ROCKET PHARMACEUTICALS, INC. | Verksamhetschef | 2025-06-18 |
| ARGENX SE | Företagsledare/Principal | 2023-06-01 |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Företagsledare/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
argenx SE
argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
TScan Therapeutics, Inc.
TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Alexion Pharma UK Ltd.
Alexion Pharma UK Ltd. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån